Form 4 for SNA Snap-on
Accepted 2026-02-17 00:00:00 ET · period of report 2026-02-12 · accession 0000091440-26-000067 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-17 | 2026-02-12 | SNA | Arregui Jesus | SVP, Pres - Commercial | F - Tax | $378.55 | -831 | 4,405 | -16% | -$314.6K |
| D | 2026-02-17 | 2026-02-12 | SNA | Arregui Jesus | SVP, Pres - Commercial | M - OptEx | — | +1,856 | 5,236 | +55% | — |
| D | 2026-02-17 | 2026-02-12 | SNA | Arregui Jesus | SVP, Pres - Commercial | D - Sale to Iss | — | -807 | 1,856 | -30% | — |
| D | 2026-02-17 | 2026-02-12 | SNA | Arregui Jesus | SVP, Pres - Commercial | M - OptEx | — | -1,856 | 0 | -100% | — |
| DM | 2026-02-17 | 2026-02-12 | SNA | Arregui Jesus | SVP, Pres - Commercial | A - Grant | $0.00 | +7,066 | 4,103 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-12 | F | D | 831 | $378.55 | 4,405.34 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-12 | M | A | 1,856 | — | 5,236.34 | D | — | — | (F1) Based on Company performance during the 2023-2025 period, 69.7% of the performance units vested (as previously disclosed, the reporting person had the opportunity to earn up to 200% of the number originally reported, subject to plan limits). |
| 3 | Derivative | Performance Units | 2026-02-12 | D | D | 807 | — | 1,856 | D | — · — to — | 807 Common Stock | (F1) Based on Company performance during the 2023-2025 period, 69.7% of the performance units vested (as previously disclosed, the reporting person had the opportunity to earn up to 200% of the number originally reported, subject to plan limits). (F3) 1 for 1. |
| 4 | Derivative | Performance Units | 2026-02-12 | M | D | 1,856 | — | 0 | D | — · — to — | 1,856 Common Stock | (F1) Based on Company performance during the 2023-2025 period, 69.7% of the performance units vested (as previously disclosed, the reporting person had the opportunity to earn up to 200% of the number originally reported, subject to plan limits). (F3) 1 for 1. |
| 5 | Derivative | Performance Units | 2026-02-12 | A | A | 1,975 | $0.00 | 1,975 | D | — · — to — | 1,975 Common Stock | (F3) 1 for 1. (F7) If the Company achieves certain goals over the 2026-2028 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits. |
| 6 | Derivative | Restricted Stock Units | 2026-02-12 | A | A | 988 | $0.00 | 988 | D | — · 2029-02-12 to 2029-02-12 | 988 Common Stock | (F3) 1 for 1. (F6) The restricted stock units vest three years from the grant date on the date listed above, assuming continued employment. |
| 7 | Derivative | Stock Appreciation Rights | 2026-02-12 | A | A | 4,103 | $0.00 | 4,103 | D | $378.55 · 2027-02-12 to 2036-02-12 | 4,103 Common Stock | (F5) This transaction was a stock appreciation rights grant. Accordingly, the reporting person did not pay a price to obtain the stock appreciation rights grant. (F4) Original stock appreciation rights grant vests in three annual installments beginning on the date listed in the "Date Exercisable" column. |